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Abstract   
Background: Diets with a high postprandial glycemic response may contribute to long-term 
development of insulin resistance and diabetes, however previous epidemiological studies are 
conflicting on whether glycemic index (GI) or glycemic load (GL) are dietary factors associated 
with the progression. Our objectives were to estimate GI and GL in a group of older women, and 
evaluate cross-sectional associations with insulin resistance. 
Subjects and Methods: Subjects were 329 Australian women aged 42-81 years participating in year 
three of the Longitudinal Assessment of Ageing in Women (LAW). Dietary intakes were assessed 
by diet history interviews and analysed using a customised GI database. Insulin resistance was 
defined as a homeostasis model assessment (HOMA) value of >3.99, based on fasting blood 
glucose and insulin concentrations.  
Results: GL was significantly higher in the 26 subjects who were classified as insulin resistant 
compared to subjects who were not (134±33 versus 114±24, P<0.001). In a logistic regression 
model, an increment of 15 GL units increased the odds of insulin resistance by 2.09 (95%CI 1.55, 
2.80, P<0.001) independently of potential confounding variables. No significant associations were 
found when insulin resistance was assessed as a continuous variable.  
Conclusions: Results of this cross-sectional study support the concept that diets with a higher GL 
are associated with increased risk of insulin resistance. Further studies are required to investigate 
whether reducing glycemic intake, by either consuming lower GI foods and/or smaller serves of 
carbohydrate, can contribute to a reduction in development of insulin resistance and long-term risk 
of type 2 diabetes. 
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Introduction   
Glycemic intake, measured by glycemic index (GI) and glycemic load (GL), describes the rate of 
digestion of carbohydrate foods and absorption of glucose into the bloodstream. These empirically-
derived measures provide a way to quantify the impact of carbohydrate on circulating blood glucose 
concentrations (Jenkins et al, 1981). The GI of a food represents the rise in blood glucose two hours 
after consumption of a 50 g serve of the food compared to 50 g glucose, and is given as a 
percentage (Jenkins et al, 1981). The GL of a food varies with serve size and is calculated as the 
food’s GI multiplied by the amount of carbohydrate in the serve. Meals low in glycemic intake 
result in lowered postprandial increases in blood glucose and insulin concentrations (Holt et al, 
1997), however the possible long-term impact of sustained low glycemic diets on reducing the risk 
of chronic disease such as type 2 diabetes mellitus is currently an area of controversy (Miles, 2008).  
 
One early predictor of type 2 diabetes is the condition of insulin resistance (Weyer et al, 1999, 
Martin et al, 1992), defined as the inability of a known quantity of insulin to increase glucose 
uptake and utilisation in an individual as much as it does in a healthy population (Lebovitz, 2001). 
In a five year follow-up study of 6000 adults, people who were insulin resistant were 15 times more 
likely to develop diabetes than people who were not (Barr et al, 2006). The transition from insulin 
resistance to clinical diabetes is thought to be a progressive process that is associated with a decline 
in pancreatic islet beta-cell function and cell mass (Kahn, 2003). Dietary factors that could slow or 
reverse this progression have the potential to reduce the risk of developing diabetes.  
 
In a meta-analysis of prospective observational studies, Barclay et al (2008) concluded that diets 
with a high GI or GL independently increased the risk of type 2 diabetes, although not all studies 
were supportive. Previous cross-sectional studies of insulin resistance have found significant 
positive associations with both GI and GL (McKeown et al, 2004) or no significant associations 
(Lau et al, 2005, Liese et al, 2005).   
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A potential limitation of these previous observational studies, noted by Barclay et al (2008), has 
been that the food frequency questionnaires (FFQ) used to measure dietary intake were not 
validated for GI or GL using another dietary method or against an objective standard. FFQ's have 
been the tool of choice for assessing dietary intake in populations, as they are feasible and 
economical to administer on a large scale and analysis is relatively quick using the specified food 
list as a template for data entry. However the food and serve size options listed could restrict the 
amount and type of information obtained compared to a food record or diet history interview, in 
which individual foods and serve sizes are directly quantified (Cameron and Van Staveren, 1988, 
Sempos, 1992). The impact of glycemic intake on the risk of chronic diseases could be 
underestimated if individual serve sizes for carbohydrate foods are not accurately quantified, 
contributing to some of the inconsistent findings from previous studies. The current study was 
conducted as part of a larger assessment of ageing in a group of older women. Our objectives were 
to estimate usual dietary GI and GL using a detailed diet history interview and to evaluate 
associations with insulin resistance. 
 
Methods  
Subjects 
A total of 511 women participated in the Longitudinal Assessment of Ageing in Women (LAW 
study), an age-stratified multidisciplinary study conducted at the Royal Brisbane and Women's 
Hospital, Australia. At the beginning of the study, subjects were randomly selected from the 
electoral roll within four age cohorts: 40–49, 50–59, 60–69 and 70–79 years (Khoo et al, 2008). Data 
for the current study were collected during year three of the LAW study. Subjects were excluded if 
they were: confirmed by the study clinician to have diabetes based on self-report, use of medication, 
and/or fasting glucose concentrations (>6.0 mmol/L) (World Health Organisation, 1999); taking an 
oral hypoglycemic agent; unable to provide a fasting blood sample or participate in a diet history; 
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classified as under-reporters of energy intake (estimated energy intake: estimated energy 
expenditure <0.76) (Black, 2000); or if less than 85% of the carbohydrate in their diet was able to 
be allocated a GI value. Study procedures were approved by the Human Research Ethics 
Committees of Queensland University of Technology and Royal Women's Hospital. Subjects gave 
informed written consent 
 
Assessment of dietary intake 
Usual intake was assessed by a dietitian during a standardised diet history interview (Tapsell et al, 
2000, Cameron and Van Staveren, 1988) focussing on the amount and type of carbohydrate items 
consumed in a typical month over the past six months. Food models and measuring displays were 
used to help precisely assess serve sizes and detailed information was sought on foods and 
beverages, including brand names and cooking procedures. An 80-item frequency checklist was 
included to detect possible omissions from the diet history. Data were analysed using the 
Foodworks dietary analysis program (Professional Version 4.00, Xyris Software, Brisbane) and the 
Australian Food and Nutrient database of Australian foods, combined with a customised GI 
database comprising published GI values (University of Sydney, 2007, Foster-Powell et al, 2002) 
and values estimated from similar foods or calculated from constituent foods where appropriate. 
The dietary GL was calculated as the product of the GI and carbohydrate content for each food, 
summed for all foods eaten and given as a daily value. The dietary GI, given as a percentage, was 
calculated as the product of the GI and carbohydrate content for each food, summed for all foods 
eaten during the day, then divided by the total daily carbohydrate intake (Jenkins et al, 1981).  
 
Measurement of insulin resistance 
Insulin resistance was assessed using homeostasis model assessment (HOMA), where 
HOMA=fasting plasma insulin (mU/L) x fasting plasma glucose (mmol/L)/22.5 (Matthews et al, 
1985). Due to the degree of natural variation in both fasting glucose and insulin concentrations, we 
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used a HOMA cut-point to identify subjects with high HOMA results. For this study, subjects were 
categorised as insulin resistant if HOMA was >3.99 (Wahrenberg et al, 2005). As there is no 
definitive HOMA cut-point to represent insulin resistant status, associations were also investigated 
using values from 2.00 to 5.99.  
 
Measurement of potential confounding variables 
Clinical data were collected by interview with the study clinician. Menopausal and hormone therapy 
(HT) status groups were: premenopausal; HT user; post/perimenopausal and HT non-user or short-
term user (<12 months). Family history of diabetes was defined as a first-degree blood relative 
diagnosed with type 1 or type 2 diabetes mellitus. Smoking was investigated in terms of pack years 
and smoking status (never/current/ex-smoker). Subjects were classified by a physiotherapist into 
one of six physical activity levels, based on incidental and purposeful exercise (Hirvensalo et al, 
2000); these were subsequently collapsed into two levels: active (walk or other activity ≥2/week) or 
sedentary (activity <2/week) after statistical analyses showed no significant differences between 
using two or six levels. Anthropometric measures were obtained by a trained operator using 
standard methodology (Gibson, 1993). Waist and hip circumference was measured to the nearest 
0.1 cm; height was assessed to the nearest 0.1 cm with a stadiometer (Holtain Ltd, Crymych, UK) 
and weight was measured to the nearest 0.01 kg using a Seca standing scale (B.P.S Instruments, 
US). Body mass index (BMI) was calculated as weight in kilograms divided by the square of height 
in metres. Average daily intakes of saturated fat, alcohol, dietary fibre and energy were assessed 
from the diet history. 
 
Statistical analysis 
Independent t-tests were used to evaluate differences between continuous measures of glycemic 
intake based on insulin resistant status (yes/no). Chi-square tests were used to locate significant 
differences in proportions with insulin resistance between pairs of tertiles. ANOVA was used to 
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assess differences in dietary intake across tertiles of GI and GL. Multivariate logistic regression 
models were used to evaluate the relationships between insulin resistance (as a dichotomous 
measure) and glycemic intake (GI or GL), adjusted for age, age squared, BMI, waist circumference, 
family history of diabetes, menopausal and HT status, physical activity level, daily intakes of 
energy, alcohol and dietary fibre, and percent saturated fat intake. Using log HOMA measurements, 
insulin resistance was also considered as a continuous response in multivariate linear regression 
models. Step-wise removal of the variables with the least significant association with IR status (or 
log HOMA) was performed until all variables were significant. Non-significant variables were re-
tested in the parsimonious model before their exclusion was confirmed. Statistical significance was 
set to 5% and analysis was completed using the Statistical Package for Social Sciences (SPSS) for 
Windows (release 14.0). Values are expressed as mean±SD except where stated. 
 
Results 
Subjects   
Of the 511 subjects who commenced the LAW study, 470 completed a diet history in year three. 
Reasons for non-completion were inability to attend the appointment (n=24), illness (n=13), death 
(n=2), and unwillingness to participate (n=2). A further 11 were identified as reporting 
unacceptably low energy intakes and 40 did not have full data on potential confounding variables, 
leaving 419 eligible subjects. Of these, GI and GL values were not able to be allocated to 90 
subjects, with 89.7% of the total carbohydrate intake of the group allocated a GI value. The 
remaining 329 subjects were included in the statistical analysis; 7.9% (n=26) of these were 
identified as insulin resistant. Characteristics of subjects who were included were not significantly 
different to those who were not included (Table 1). Mean GI was 55.7±4.4%, with a range of 44.5-
77.2% and an interquartile range (IQR) of 52.7-58.4%. Mean GL was 115±26, with a range of 47-
236 and an IQR of 98-130. Intakes between GI tertiles were significantly different for dietary fibre, 
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protein, and fat, while intakes between GL tertiles were significantly different for energy, 
carbohydrate, dietary fibre, fat and protein (Table 2). 
 
Associations between glycemic intake and insulin resistance status 
GL was significantly higher in subjects who were insulin resistant compared to subjects who were 
not insulin resistant (P<0.001); there were no significant differences in GI (P=0.68) (Table 3). 
Subjects with insulin resistance were significantly older and had a higher BMI and waist to hip ratio 
than subjects without insulin resistance (Table 3). In a logistic regression model, an increment of 15 
GL units increased the odds of prevalent insulin resistance by 2.09 (95%CI 1.55, 2.80) 
independently of potential confounding factors (P<0.001). GI was not significantly associated with 
insulin resistant status in the model (P=0.56). When analyses were re-run to include all subjects 
who participated in the dietary analysis (n=470), an increment of 15 GL units increased the odds of 
insulin resistance by 1.45 (95% CI 1.08, 1.95). 
 
Insulin resistance was significantly higher in the third GL tertile (highest) compared to second 
(P=0.04) and first (P=0.002) tertiles (Figure 1). In a logistic regression model, adjusted for 
potential confounding factors, the odds of insulin resistance for subjects in the third GL tertile were 
12.7 times higher compared with the first tertile (95%CI 1.6, 100, P=0.02) and 6.3 times higher 
compared with the second tertile (95%CI 1.4, 28.6, P=0.02). Conversely, the proportion with 
insulin resistant status was not statistically different between GI tertiles (P=0.69) or between GI 
tertiles after adjustment for potential confounding variables (P=0.25). 
 
In logistic regression models adjusted for potential confounding variables, GL remained a 
significant predictor of insulin resistant status classified using HOMA cut-points from 3.25 to 4.99, 
in which the proportion of subjects classified as insulin resistant varied from 12% to 3%. The 
highest odds were observed for HOMA values between 3.75 and 4.99 (Table 4). Results of separate 
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multivariate linear regression models using HOMA as a continuous measure of insulin resistance 
showed no statistically significant association between GI (P=0.44) or GL (P=0.18). 
 
Discussion  
We observed an independent positive relationship between GL and insulin resistance in a group of 
Australian women participating in the Longitudinal Assessment of Ageing in Women (LAW). 
Mean GL intake was 18% higher in women with insulin resistance compared to those without 
insulin resistance (P<0.001) (Table 3). When adjusted for potential confounding variables in a 
logistic regression model, an increase of 15 GL units was associated with a two-fold increase in the 
odds of insulin resistance. This trend was also observed with GL tertiles, although the wide 
confidence intervals indicated that the categorical variable may be an imprecise measure of 
glycemic intake in this group (Figure 1). However, the magnitude and consistency of this effect 
supports a clinically-significant association between GL and insulin resistance in the LAW women.  
 
In contrast to the GL findings, there was no significant association between GI and insulin 
resistance, either unadjusted or adjusted for potential confounding variables. Measures of GI and 
GL differ in quantification of glycemic intake. The GI ranks foods according to the digestion and 
absorption of the carbohydrate, and is a measure of the area under the 2-hour postprandial blood 
glucose curve after consuming the food, in relation to the same quantity of glucose (Jenkins et al, 
1981). A low GI is achieved by consuming the majority of carbohydrate in the diet from low GI 
foods and is independent of total carbohydrate intake, with our results showing no significant 
difference in carbohydrate intake between tertiles of GI (Table 2). The GL represents the GI while 
also taking into account the carbohydrate content of the food. It is designed to capture the 
magnitude of the effect of dietary carbohydrates on postprandial blood glucose concentrations. A 
low GL can be achieved by consuming a low GI, moderate carbohydrate diet but also a moderate 
GI, low carbohydrate diet. Barclay et al (2005) proposed that for diets with the same GL, one with a 
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high amount of carbohydrate from low GI foods has potentially more beneficial metabolic effects 
than one with a low amount of carbohydrate from high GI foods. In our cross-sectional study, we 
were not able to distinguish between these alternatives, and further studies are required to clarify the 
metabolic effects of GL within differing dietary patterns. 
   
Our study supports a proposal by Hu et al (2001) that GL is a more physiologically-relevant 
measure than GI in terms of associated risk with chronic disease. However, the absence of a 
significant association with GI is not conclusive, due to the limited variation of intakes in the LAW 
women shown by the narrow IQR of 52.7-58.4% and relatively small standard deviation of 4.4%. 
Other observational studies with small standard deviations have not reported significant 
associations with GI (Liese et al, 2005, Zhang et al, 2006). Sahyoun et al. (2008) also noted that 
homogeneity of glycemic intake values within their population could have decreased the likelihood 
of an association. Buyken and Liese (2005) observed that the strongest association between GI and 
risk of diabetes was shown in the study with the largest variation in GI intake (Hodge et al, 2004). 
The wider variation in values for GL that we observed in the LAW cohort may have contributed to 
the significant association we found between GL and insulin resistance.  
 
The HOMA cut-point to define insulin resistant status has ranged from 2.0 to 4.65 in different 
studies.  The original research showed HOMA values for subjects without diabetes were 
approximately 2.0 compared with 2.5 for subjects with diabetes (Matthews et al, 1985). In a cross-
sectional study of older Swedish men and women without diabetes, Hedblad and colleagues (Stern 
et al, 2005, Hedblad et al, 2000) chose 2.0 as the cut-off point, which marked the 75th percentile for 
HOMA scores, assuming that the top 25% of subjects were insulin resistant. Stern et al (Stern et al, 
2005, Hedblad et al, 2000) in an evaluation of European and American individuals without diabetes 
compared various methods with the euglycemic clamp and concluded that a HOMA score greater 
than 4.65 indicated insulin resistance; as this was a highly specific decision rule, authors noted that 
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the higher cut-off would likely misclassify some insulin-resistant subjects as non-insulin resistant. 
Wahrenberg et al (2005) used a 3.99 cut-off to classify insulin resistant status in Swedish subjects, 
based on the 90th percentile and previous research (Ascaso et al, 2001).  The relationship we 
observed between GL and insulin resistant status remained significant for HOMA cut-off values 
between 2.99 and 4.99, with the strongest associations observed between values of 3.75 and 3.99, 
suggesting that 3.99 was an appropriate cut-off to use in our population (Table 4). Statistically 
significant results were not seen when using a continuous measure of HOMA to represent insulin 
resistance, suggesting that significant differences in GL are only evident in subjects with clinically 
high HOMA values. HOMA values can range from less than one to 2.7 based on fasting glucose 
and insulin concentrations considered to be normal (Dunstan et al, 2002, Worthley, 2003), and use 
of HOMA as a continuous measure may mask potential associations with dietary factors.  
 
Although the precise cellular mechanisms of insulin resistance are not yet clear (Shulman, 2000, 
Petersen and Shulman, 2006), our finding is supported by proposed mechanisms to explain how 
high glycemic intakes could promote insulin resistance. Sustained high postprandial glucose 
concentrations resulting from meals with a high glycemic response can lead to increased storage of 
triglycerides within muscle cells (Cooney and Storlien, 1994), and skeletal muscle triglyceride 
concentration has been shown to be inversely related to insulin action in both animal models 
(Storlien et al, 1991) and humans (Pan et al, 1997, Petersen and Shulman, 2006). Postprandial 
hyperglycemia has also been shown to contribute to oxidative stress with production of reactive 
oxygen species (Stamler et al, 1993, Ceriello et al, 1998, Marfella et al, 2001) that could damage 
pancreatic beta cells and possibly affect the production of insulin (Augustin et al, 2002). These beta 
cells are particularly at risk as they have lower levels of intrinsic antioxidant defences compared to 
other tissues (Robertson, 2004). However, the results of our cross-sectional study cannot be used to 
infer a causal relationship between GL intake and insulin resistance. Insulin resistance has the 
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potential to create an environment of a relative glucose deficiency, which may trigger preferences 
for foods high in GI and carbohydrate, which in turn produce a higher glycemic response. 
 
A strength of our study was the comprehensive assessment of glycemic intake. Individual diet 
history interviews were used to collect detailed data on carbohydrate serve sizes and the range of 
items consumed during the day. This allowed precise characterisation of GI and GL intakes for each 
woman and minimised measurement error, an important consideration when evaluating possible 
associations between glycemic intake and individual risk of chronic diseases. Imprecise estimates of 
GI and GL from FFQs that were not originally designed to assess GI or GL or validated for this 
purpose, may have partially contributed to contradictory findings in previous observational studies 
of insulin resistance (Barclay et al, 2008, McKeown et al, 2004, Lau et al, 2005, Liese et al, 2005). 
 
A potential limitation of our study was that 90 women were excluded as less than 85% of their 
carbohydrate intake was able to be allocated a GI value. This criterion was set to ensure the 
estimated values were as precise as possible; a lower value would have included more subjects but 
decreased the precision of the values. There were no statistically significant differences between 
subjects allocated and not allocated GI values (Table 1), although there were non-significant trends 
towards a greater proportion of younger women and women with higher BMI in the group who 
were not allocated a value. Results showed that increasing the subject numbers to include the 
excluded subjects decreased the strength but did not change the direction or significance of the 
findings.    
 
From this study of Australian women, we conclude that higher dietary GL is associated with a 
statistically significant increased risk of being insulin resistant, after adjustment for potential 
confounding variables. Intervention studies are required to investigate whether reducing glycemic 
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intake, by either consuming lower GI foods and/or smaller serves of carbohydrate, can contribute to 
a reduction in development of insulin resistance and long-term risk of type 2 diabetes.  
 
 
 
 
 13  
References   
Ascaso J, Romero P, Real J, Priego A, Valldecabres C & Carmena R (2001) Insulin resistance 
quantification by fasting insulin plasma values and HOMA index in non diabetic subjects. 
Med Clin, 117, 530-33. 
Augustin LS, Franceschi S, Jenkins DJ, Kendall CW & La Vecchia C (2002) Glycemic index in 
chronic disease: a review. Euro J Clin Nutr, 56, 1049-71. 
Barclay AW, Brand-Miller JC & Wolever TMS (2005) Glycemic index, glycemic load, and 
glycemic response are not the same. Diabetes Care, 28, 1839-40. 
Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, et al. (2008) Glycemic 
index, glycemic load, and chronic disease risk- a meta-analysis of observational studies. Am 
J Clin Nutr, 87, 627-37. 
Barr E, Magliano D, Zimmet P, Polkinghorne K, Atkins R, Dunstan D, et al. (2006) AusDiab 2005 
- The Australian Diabetes, Obesity and Lifestyle Study: Followup Report, International 
Diabetes Institute, Melbourne. 
Black AE (2000) The sensitivity and specificity of the Goldberg cut-off for EI: BMR for identifying 
diet reports of poor validity. Euro J Clin Nutr, 54, 395-404. 
Buyken A & Liese A (2005) Dietary glycemic index, glycemic load, fiber, simple sugars, and 
insulin resistance: the Inter99 Study: response to Lau et al. Diabetes Care, 28, 2986. 
Cameron M & Van Staveren W (Eds.) (1988) Manual on Methodology for Food Consumption 
Studies,  Oxford University Press, New York. 
Ceriello A, Bortolotti N, ACrescentini, EMotz, Lizzio S, Russo A, et al. (1998) Antioxidant 
defences are reduced during the oral glucose tolerance test in normal and non-insulin-
dependent diabetic subjects. Euro J Clin Invest, 28, 329-33. 
Cooney GJ & Storlien LH (1994) Insulin action, thermogenesis and obesity. Clin Endocr Metab, 8, 
481-507. 
Dunstan DW, Zimmet PZ, Welborn TA, de Courten MP, Cameron AJ, Sicree RA, et al. (2002) The 
rising prevalence of diabetes and impaired glucose tolerance: The Australian diabetes, 
obesity and lifestyle study. Diabetes Care, 25, 829-34. 
Foster-Powell K, Holt S & Brand-Miller J (2002) International table of glycemic index and 
glycemic load values: 2002. Am J Clin Nutr, 76, 5-56. 
Gibson R (1993) Nutritional Assessment: A Laboratory Manual, Oxford University Press, New 
York. 
Hedblad B, Nilsson P, Janzon L & Berglund G (2000) Relation between insulin resistance and 
carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-
sectional study in Malmö, Sweden. Diabet Med, 17, 299-307. 
Hirvensalo M, Lintunen T & Rantanen T (2000) The continuity of physical activity - a retrospective 
and prospective study among older people. Scand J Med Sci Sports, 10, 37-41. 
 14  
Hodge AM, English DR, O'Dea K & Giles GG (2004) Glycemic index and dietary fiber and the risk 
of type 2 diabetes. Diabetes Care, 27, 2701-06. 
Holt SH, Miller JCB & Petocz P (1997) An insulin index of foods: The insulin demand generated 
by 1000-kj portions of common foods. Am J Clin Nutr, 66, 1264-76. 
Hu FB, van Dam RM & Liu S (2001) Diet and risk of Type II diabetes: the role of types of fat and 
carbohydrate. Diabetologia, 44, 805-17. 
Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. (1981) Glycemic 
index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr, 34, 362-
66. 
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the 
pathophysiology of Type 2 diabetes Diabetologia, 46, 3-19. 
Khoo SK, Franzcog, O'Neill S, Travers C, Oldenburg B & the LAW Study Group (2008) Age-
related changes relevant to health in women: design, recruitment, and retention strategies for 
the Longitudinal Assessment of Women (LAW) study. J Womens Health, 17, 135-46. 
Lau C, Færch K, Glümer C, Tetens I, Pedersen O, Carstensen B, et al. (2005) Dietary glycemic 
index, glycemic load, fiber, simple sugars, and insulin resistance: The Inter99 study. 
Diabetes Care, 28, 1397-403. 
Lebovitz H (2001) Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes, 
109, S135-48. 
Liese A, Schulz M, Fang F, Wolever T, D'Agostino RJ, Sparks K, et al. (2005) Dietary glycemic 
index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, 
secretion, and adiposity in the Insulin Resistance Atherosclerosis Study. Diabetes Care, 28, 
2832-38. 
Marfella R, Quagliaro L, Nappo F, Ceriello A & Giugliano D (2001) Acute hyperglycemia induces 
an oxidative stress in healthy subjects. J Clin Invest, 108, 635-36. 
Martin B, Warram J, Krolewski A, Bergman R, Soeldner J & Kahn C (1992) Role of glucose and 
insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up 
study. The Lancet, 340, 925-29. 
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D & Turner RC (1985) Homeostasis model 
assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin 
concentrations in man. Diabetologia, 28, 412-19. 
McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PWF & Jacques PF (2004) Carbohydrate 
nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the 
Framingham Offspring Cohort. Diabetes Care, 27, 538-46. 
Miles J (2008) A role for the glycemic index in preventing or treating diabetes? Am J Clin Nutr, 87, 
1-2. 
Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, et al. (1997) Skeletal muscle 
triglyceride levels are inversely related to insulin action. Diabetes, 46, 983-88. 
Petersen KF & Shulman GI (2006) Etiology of Insulin Resistance. Am J Med, 119, S10-16. 
 15  
Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in 
pancreatic islet beta cells in diabetes. J Biol Chem, 279, 42351-54. 
Sahyoun NR, Anderson AL, Tylavsky FA, Lee JS, Sellmeyer DE, Harris TB, et al. (2008) Dietary 
glycemic index and glycemic load and the risk of type 2 diabetes in older adults. Am J Clin 
Nutr, 87, 126-31. 
Sempos CT (1992) Invited commentary: Some limitations of semiquantitative food frequency 
questionnaires. Am J Epidemiol, 135, 1127-32. 
Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest, 106, 171-76. 
Stamler J, Vaccaro O, Neaton J & Wentworth D (1993) Diabetes, other risk factors, and 12-yr 
cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. 
Diabetes Care, 16, 434-44. 
Stern S, Williams K, Ferrannini E, Defronzo R, Bogardus C & Stern M (2005) Identification of 
individuals with insulin resistance using routine clinical measurements. Diabetes, 54, 333-
39. 
Storlien L, Jenkins A, Chisholm D, Pascoe W, Khouri S & Kraegen E (1991) Influence of dietary 
fat composition on development of insulin resistance in rats. Relationship to muscle 
triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes, 40, 280-89. 
Tapsell LC, Brenninger V & Barnard J (2000) Applying conversation analysis to foster accurate 
reporting in the diet history interview. J Am Diet Assoc, 100, 818-24. 
University of Sydney (2007) Home of the Glycemic Index - GI Database, online resource, accessed 
<http://www.glycemicindex.com/>. 
Wahrenberg H, Hertel K, Leijonhufvud B-M, Persson L-G, Toft E & Arner P (2005) Use of waist 
circumference to predict insulin resistance: retrospective study. Br Med J, 330, 1363-64. 
Weyer C, Bogardus C, Mott DM & Pratley RE (1999) The natural history of insulin secretory 
dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin 
Invest, 104, 787-94. 
World Health Organisation (1999) Definition, diagnosis and classification of diabetes mellitus and 
its complications: report of a WHO consultation. Geneva, World Health Organisation. 
Worthley L (Ed.) (2003) The Australian Short Course on Intensive Care Medicine,  The 
Australasian Academy of Critical Care Medicine, Bedford Park, South Australia. 
Zhang C, Liu S, Solomon CG & Hu FB (2006) Dietary fiber intake, dietary glycemic load, and the 
risk for gestational diabetes mellitus. Diabetes Care, 29, 2223-30. 
 
 
 16  
 
Table 1. Characteristics of LAW study subjects who were and were not allocated GI and GL values 
 
Characteristic 
Subjects 
allocated a 
GI/GL value† 
n=329 
Subjects not 
allocated a 
GI/GL value† 
n=90 
P value‡ 
Total 
eligible 
subjects 
n=419 
Age group (%)   0.07  
   42-51 years 23.1 35.6  25.8 
   52-61 years 25.5 21.1  24.6 
   62-71 years 28.0 18.9  26.0 
   72-81 years 23.4 24.4  23.6 
     
Activity level (%)   0.30  
   Active (walk or other activity ≥ 2/week) 66.0 71.9  67.3 
   Sedentary (activity less than 2/week) 34.0 28.1  32.7 
     
Menopausal and hormone therapy (HT) 
status (%) 
  0.29  
   Premenopausal 12.7 19.3  14.2 
   Using HT ≥12 months 43.8 39.8  42.9 
Peri or postmenopausal, and using HT 
<12 months 
43.5 40.9  42.9 
     
Smoking status (%)   0.80  
   Non-smoker 54.7 53.3  54.4 
   Ex-smoker 36.5 35.6  36.3 
   Current smoker 8.8 11.1  9.3 
 
BMI (kg/m2), mean±SD 26.5±4.8 27.6±5.2 0.06 26.8 ± 4.9
Waist to hip ratio, mean±SD 0.80±0.1 0.80 ± 0.1 0.99 0.80 ± 0.1
Homeostasis model assessment, mean±SD 1.9±1.3 1.9±1.9 0.94 1.9±1.5 
†Dietary GI and GL values were allocated if above or equal to 85% of daily carbohydrate intake was assigned a GI 
value.  
‡P value for comparison of proportions (chi-square tests) or means (independent t-tests) between the group in which 
GI/GL could be allocated and the group in which GI/GL could not be allocated. 
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Table 2.   Comparison of daily dietary intake between tertiles of glycemic index (GI) and glycemic 
load (GL) (n=329) 
 
Daily nutrient intake 
(mean±SD) 
GI Tertile 
P 
GL Tertile 
P  
0-54.0 54.0-57.4 57.4+ 0-103 103-125 125+ 
Energy (MJ) 8.42 ± 1.4 8.47 ± 1.2 8.41 ± 1.4 0.94 7.54 ± 1.1 8.46 ± 1.0 9.27 ± 1.1 <0.01
Carbohydrate (g) 232 ± 43 225 ± 41 225 ± 54 0.43 181 ± 25 226 ± 20 274 ± 23 <0.01
Carbohydrate (%) 47.9 ± 5.8  46.1 ± 6.5 46.0 ± 7.5 0.06 42.0 ± 5.7 46.7 ± 5.9 51.2 ± 4.9 <0.01
GI  51.1 ± 2.3 55.6 ± 1.0 60.2 ± 2.9 <0.01 54.7 ± 4.3 5.54 ± 4.4 56.9 ± 4.1 <0.01
GL  109 ± 22 113 ± 22 123 ± 30 <0.01 88.9 ± 11 113 ± 7  143 ± 18 <0.01
Dietary fibre (g) 30.0 ± 6.6 26.7 ± 7.3 25.2 ± 7.3 <0.01 24.4 ± 6.6 28.0 ± 7.1 29.3 ± 7.5 <0.01
Protein (g) 91.8 ± 17 87.5 ± 14 83.7 ± 14 <0.01 83.6 ± 15 87.2 ± 15 91.9 ± 16 <0.01
Protein (%) 19.0 ± 2.9 18.0 ± 2.5 17.4 ± 2.7 <0.01 19.3 ± 3.1 17.9 ± 2.5 17.2 ± 2.3 <0.01
Fat (g) 69.5 ± 20 72.3 ± 18 74.6 ± 19 0.12 69.6 ± 18 73.0 ± 20 73.9 ± 18 0.21 
Fat (%) 30.8 ± 6.1 32.0 ± 5.7 33.3 ± 5.7 0.01 34.3 ± 5.7 32.1 ± 6.2 29.7 ± 4.8 <0.01
Saturated fat (g) 24.2 ± 8.7 26.8 ± 8.4 27.8 ± 9.6 0.01 24.8 ± 8.7 26.5 ± 9.8 27.5 ± 8.4 0.08 
Saturated fat (%) 10.5 ± 2.8  11.6 ± 3.0 12.2 ± 3.8 <0.01 12.1 ± 3.6 11.4 ± 3.4 10.9 ± 2.7 0.03 
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Table 3.   Comparison of glycemic intake and other characteristics between subjects who were and 
who were not classified as insulin resistant†.  
 
Characteristic (mean±SD) 
Non IR† 
n=303 
IR† 
n=26 
P value‡ 
Total 
n=329 
GI (%) 55.7±4.5 56.0±3.3 0.68 55.7±4.4
GL 114±24 134±33 <0.01 115±26
Energy intake (MJ) 8.4±1.4 8.8±1.5 0.15 8.4±1.4
Age (years) 61±10 66±9 0.02 62±10 
BMI (kg/m2) 26.1±4.4 31.7±6.6 <0.01 26.5±4.8
Waist to hip ratio 0.80±0.1 0.84±0.0 <0.01 0.80±0.1
Homeostasis model assessment (HOMA) 1.6±0.8 5.4±1.5 <0.01 1.9±1.3
†Subjects were classified as insulin resistant (IR) if HOMA was >3.99. 
‡P value for comparison of means between subjects who were and were not classified as insulin resistant (t-tests). 
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Table 4.   Variation in the odds of insulin resistant status for a one unit increase in glycemic load 
using different homeostasis model assessment (HOMA) cut-points in multivariate 
logistic regression models.  
 
HOMA cut-point for 
insulin resistant status  (≥) 
Number (%) of subjects classified 
as insulin resistant 
Odds of insulin resistant 
status (95% CI) 
1.99 116 (35%) 1.00 (0.99, 1.02) 
2.50 79 (24%) 1.01 (0.99, 1.03) 
2.99 44 (13%) 1.02 (1.00, 1.04) 
3.25 39 (12%) 1.03 (1.00, 1.05) 
3.50 32 (10%) 1.04 (1.01, 1.06) 
3.75 28 (9%) 1.05 (1.02, 1.08) 
3.99† 26 (8%) 1.05 (1.03, 1.07) 
4.25 20 (6%) 1.03 (1.00, 1.07) 
4.50 15 (5%) 1.06 (1.01, 1.11) 
4.75 13 (4%) 1.05 (1.00, 1.10) 
4.99 11 (3%) 1.06 (1.01, 1.11) 
5.50 10 (3%) 1.04 (1.00, 1.09) 
5.99 8 (2%) 1.05 (1.00, 1.10) 
       †cut-point used in current study 
 
 
 
 
 
 
 
 
 
Figure 1.    Percentage of subjects in glycemic index (GI) and glycemic load (GL) 
tertiles who were insulin resistant (black) compared with subjects who 
were not insulin resistant (cross hatch). Percentage of insulin resistant 
subjects in each tertile is stated at top of columns. 
* 3rd tertile (highest) significantly greater than 1st tertile (lowest) (P<0.002) and 2nd  tertile 
(P<0.04). 
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